Use DERMA120 to get ₹120 off on Order ₹2999+

Product Description:
Key Ingredients:
Composition:
Key Uses/Benefits:
How to Use:
Safety/Storage Information:
Country Of Origin:
India
Marketed By:
Ethinext Pharma Pvt Ltd
B 407 Imperial Heights
Opp Big Bazaar 150 Ft
Ring Road Rajkot 360005
Gujarat India
India
Frequently Asked Questions (FAQs):
Minosilk F 5% Topical Solution is a prescription scalp formulation designed for male pattern hair thinning or androgenetic alopecia. It combines Minoxidil 5% w/v with Finasteride 0.1% w/v to support hair regrowth, reduce progressive thinning, and improve hair density with consistent use.
It contains Minoxidil 5% w/v and Finasteride 0.1% w/v. Minoxidil supports blood flow around the hair follicles, while Finasteride helps reduce scalp DHT formation associated with male pattern hair thinning.
Minoxidil is a vasodilator that helps widen blood vessels around scalp hair follicles, improving local blood flow and supporting follicle activity. With regular use, this can help encourage hair regrowth and improve the appearance of hair density.
Finasteride inhibits the 5-alpha-reductase enzyme involved in converting testosterone into dihydrotestosterone, or DHT. Reducing DHT activity in the scalp helps support follicles affected by androgenetic hair thinning and may help slow progressive miniaturisation.
Current product guidance positions Minosilk F for men with androgenetic alopecia and states that it is not indicated for women. Women should not use this finasteride-containing formulation unless specifically advised by an appropriate healthcare professional.
Apply it to a clean and completely dry scalp. Applying the solution directly to the scalp rather than the hair helps ensure that the active ingredients reach the areas of thinning.
Apply the quantity advised by your healthcare professional or stated on the current pack directly to the thinning scalp areas. Spread it gently with the fingertips, avoid allowing the solution to run onto the face, and wash your hands thoroughly before and after application.
The exact frequency should follow your prescriber's instructions and the current physical pack. Do not apply more frequently or use a larger quantity than advised, as excess application does not produce faster hair growth and may increase unwanted effects.
Avoid shampooing or significantly wetting the scalp for approximately 4 hours after application, unless your prescriber gives different instructions. This allows adequate contact time on the scalp.
It is advisable not to use a hairdryer immediately after application. Current guidance recommends waiting at least 4 hours before washing or blow-drying the hair, as early drying or washing may reduce product contact with the scalp.
Some users may notice an increase in hair shedding during approximately the first two weeks as the hair-growth cycle changes. This is usually temporary, but persistent, severe, or concerning shedding should be discussed with a healthcare professional.
Visible changes usually require consistent use over several months. Initial new hair may appear fine, soft, or lighter in colour before becoming more noticeable. If there is little or no improvement after around 4–6 months, professional reassessment is advisable.
Continued use is generally necessary to maintain the hair-growth support provided by the formulation. After discontinuation, newly supported hair may gradually be lost and pattern thinning can become noticeable again over time.
Use it only on the scalp and avoid contact with the eyes, nose, mouth, broken skin, or highly irritated areas. Rinse thoroughly with water if accidental contact occurs. Inform your healthcare professional about heart-related concerns and other ongoing prescriptions before use.
Possible unwanted effects include scalp burning, itching, redness, dryness, flaking, or unwanted hair growth outside the application area. Finasteride-containing formulations may also be associated with effects such as reduced libido, erectile difficulties, or ejaculation-related concerns in some users. Persistent or troublesome symptoms should be professionally assessed.
No. Finasteride-containing topical formulations should not be used during pregnancy or breastfeeding, and current product guidance does not indicate Minosilk F for women.
Keep the bottle tightly closed and store below 30°C, protected from excess heat and direct sunlight. Keep it out of reach of children and pets. Minoxidil can be highly toxic to pets, particularly cats, so prevent contact with freshly applied scalp areas, spills, towels, pillows, or clothing carrying the solution.
